Boothbay Fund Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Boothbay Fund Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,711	Closed	-$270K	–	2262
2021 Q3	$270K	Buy	+35,711	New	+$117K	0.01%	1386
2021 Q2	–	Sell	-69,500	Closed	-$1.03M	–	2143
2021 Q1	$1.03M	Buy	+69,500	New	+$386K	0.04%	580

Other funds holding WGSWW

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

DCP

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Boothbay Fund Management's WGSWW Position: Q4 2021 in Review

Boothbay Fund Management sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2021, closing a stake of 35,711 shares — an estimated $270K sold.

Boothbay Fund Management first reported a position in WGSWW in Q1 2021 and held it in 2 quarters. The position peaked at $1.03M in Q1 2021. 33 funds tracked by Wall St. Rank hold WGSWW as of Q4 2021.

Boothbay Fund Management reported no remaining GeneDx Holdings Warrant position as of Q4 2021 after selling out during the quarter.
Boothbay Fund Management sold 35,711 GeneDx Holdings Warrant shares in Q4 2021, an estimated $270K.
Boothbay Fund Management first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 2 quarters.
Boothbay Fund Management's GeneDx Holdings Warrant position peaked at $1.03M in Q1 2021.
33 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.